We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ANIP

Price
65.56
Stock movement up
+0.52 (0.57%)
Company name
ANI Pharmaceuticals Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
1.98B
Ent value
2.69B
Price/Sales
3.56
Price/Book
4.59
Div yield
-
Div growth
-
Growth years
-
FCF payout
2.21%
Trailing P/E
-
Forward P/E
11.50
PEG
-
EPS growth
-4.74%
1 year return
48.85%
3 year return
33.85%
5 year return
22.98%
10 year return
5.00%
Last updated: 2025-09-12

DIVIDENDS

ANIP does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF21.28
Price to FCF26.84
Price to EBITDA30.91
EV to EBITDA42.04

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales3.56
Price to Book4.59
EV to Sales4.84

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count21.69M
EPS (TTM)-0.37
FCF per share (TTM)3.80

Income statement

Loading...
Income statement data
Revenue (TTM)555.46M
Gross profit (TTM)287.53M
Operating income (TTM)8.78M
Net income (TTM)-7.09M
EPS (TTM)-0.37
EPS (1y forward)7.68

Margins

Loading...
Margins data
Gross margin (TTM)51.76%
Operating margin (TTM)1.58%
Profit margin (TTM)-1.28%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash144.98M
Net receivables196.36M
Total current assets521.30M
Goodwill60.43M
Intangible assets569.83M
Property, plant and equipment0.00
Total assets1.29B
Accounts payable60.89M
Short/Current long term debt625.36M
Total current liabilities189.93M
Total liabilities856.58M
Shareholder's equity430.80M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)92.90M
Capital expenditures (TTM)19.25M
Free cash flow (TTM)73.64M
Dividends paid (TTM)1.63M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-1.65%
Return on Assets-0.55%
Return on Invested Capital-0.67%
Cash Return on Invested Capital6.97%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open90.60
Daily high91.54
Daily low89.29
Daily Volume644K
All-time high375.84
1y analyst estimate95.50
Beta0.61
EPS (TTM)-0.37
Dividend per share-
Ex-div date-
Next earnings date5 Nov 2025

Downside potential

Loading...
Downside potential data
ANIPS&P500
Current price drop from All-time high-75.75%-1.46%
Highest price drop-98.57%-56.47%
Date of highest drop25 Jun 20139 Mar 2009
Avg drop from high-77.48%-10.99%
Avg time to new high397 days12 days
Max time to new high5216 days1805 days
COMPANY DETAILS
ANIP (ANI Pharmaceuticals Inc) company logo
Marketcap
1.98B
Marketcap category
Small-cap
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Employees
897
Investor relations
-
SEC filings
CEO
Arthur S. Przybyl
Country
USA
City
Baudette
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...